Delivery Order SPE2DB24D2003-SPE2DB25FXLH9
- Not listed
- The Defense Logistics Agency awarded a $3,966.24 delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Repatha 140 mg/ml syringes. This firm fixed-price contract, with an ultimate completion date of June 16, 2025, represents a pediatric delivery order under AmerisourceBergen's larger pharmaceutical support vehicle with DLA. The award was made through open competition with no set-aside designation, and performance will occur at the company's corporate headquarters in...
- The Defense Logistics Agency awarded a $22,429.36 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied to the place of performance in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $40,818.37 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a specialized pharmaceutical product used in cardiovascular disease management. This competitively awarded, firm fixed price contract was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a $12,894 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pharmaceutical supplies. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of September 9, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,742.98 for Repatha 140 mg/ml SureClick pharmaceutical supplies. The contract, executed on May 20, 2025, with an ultimate completion date of May 21, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. This firm fixed-price delivery order, valued at $6,244.23, represents a non-competitive child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), a $1 billion agreement running through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $1,203.06 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price contract, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance will occur at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector pharmaceutical product. This firm fixed-price delivery order, valued at $20,898.64, represents a non-competitive award with an ultimate completion date of September 11, 2025. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $27,040.46 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $44,398.54 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This competitive, firm fixed-price contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLH9Delivery Order
The Defense Logistics Agency awarded a $3,262.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml syringes, with an ultimate completion date of August 5, 2025. This competitive award, issued on August 4, 2025, carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military personnel and veteran healthcare needs worldwide. This specific delivery order for Repatha, a cardiovascular medication used to treat high cholesterol, reflects the contractor's ongoing role in fulfilling specialized pharmaceutical requirements for the federal government through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/4/25 |